122 related articles for article (PubMed ID: 27446415)
1. Ikaros expression sensitizes leukemic cells to the chemotherapeutic drug doxorubicin.
He L; Gao S; Zhu Z; Chen S; Gu H
Oncol Lett; 2016 Aug; 12(2):1178-1182. PubMed ID: 27446415
[TBL] [Abstract][Full Text] [Related]
2. Ikaros is degraded by proteasome-dependent mechanism in the early phase of apoptosis induction.
He LC; Xu HZ; Gu ZM; Liu CX; Chen GQ; Wang YF; Wen DH; Wu YL
Biochem Biophys Res Commun; 2011 Mar; 406(3):430-4. PubMed ID: 21329675
[TBL] [Abstract][Full Text] [Related]
3. KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.
Ma L; Yin C; Zhang Y; Li J; Shi L; Zhou T; Huang X; Liu Y; Cao J; Wu G; Gu H; He L
Biol Chem; 2024 May; 405(5):341-349. PubMed ID: 38424700
[TBL] [Abstract][Full Text] [Related]
4. Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma cells.
He LC; Gao FH; Xu HZ; Zhao S; Ma CM; Li J; Zhang S; Wu YL
Oncol Rep; 2012 Oct; 28(4):1399-405. PubMed ID: 22859015
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
Ramachandran C; You W; Krishan A
Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA (siRNA) against Slug induces apoptosis and sensitizes human anaplastic thyroid carcinoma cells to doxorubicin.
Pan Y; Liu P; Chen D; Dou L
Cancer Biomark; 2017; 18(4):357-366. PubMed ID: 28128736
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
9. N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF.
Kim BM; Choi YJ; Lee YH; Joe YA; Hong SH
Apoptosis; 2010 Aug; 15(8):982-93. PubMed ID: 20512627
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of Ikaros regulates the FUT4/Le
Yi L; Hu Q; Zhou J; Liu Z; Li H
Biochem Biophys Res Commun; 2019 Feb; 510(1):128-134. PubMed ID: 30683310
[TBL] [Abstract][Full Text] [Related]
11. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
[TBL] [Abstract][Full Text] [Related]
12. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation.
Szwed M; Laroche-Clary A; Robert J; Jozwiak Z
Cell Oncol (Dordr); 2016 Apr; 39(2):107-18. PubMed ID: 26611752
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment.
Mashayekhi S; Yousefi B; Tohidi E; Darband SG; Mirza-Aghazadeh-Attari M; Sadighparvar S; Kaviani M; Shafiei-Irannejad V; Kafil HS; Karimian A; Jadidi-Niaragh F; Majidinia M
J Cell Biochem; 2019 Sep; 120(9):15719-15729. PubMed ID: 31087712
[TBL] [Abstract][Full Text] [Related]
15. Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells.
Szwed M; Jozwiak Z
Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():53-63. PubMed ID: 25308442
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
[TBL] [Abstract][Full Text] [Related]
17. Endogenous tumor necrosis factor and doxorubicin sensitivity in leukemic patients.
Watanabe N
Leuk Lymphoma; 1998 Aug; 30(5-6):477-82. PubMed ID: 9711910
[TBL] [Abstract][Full Text] [Related]
18. Levistolide A synergistically enhances doxorubicin‑induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway.
Ding Y; Niu W; Zhang T; Wang J; Cao J; Chen H; Wang R; An H
Oncol Rep; 2019 Feb; 41(2):1198-1208. PubMed ID: 30483812
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines.
Szwed M; Laroche-Clary A; Robert J; Jozwiak Z
Chem Biol Interact; 2014 Sep; 220():140-8. PubMed ID: 24998637
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.
Xu B; Shi P; Fombon IS; Zhang Y; Huang F; Wang W; Zhou S
Blood Cells Mol Dis; 2011 Dec; 47(4):264-9. PubMed ID: 21911303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
